• Brian A. Nuyen
  • Jennifer L. Glick
  • Vanessa Ferrel
  • W. Christopher Mathews


This chapter discusses the descriptive epidemiology of HIV; explains the pathophysiology of HIV infection and its clinical manifestations; briefly discusses important events in the medical and public health response to the HIV epidemic; reviews the impact of minority stress and intersectional vulnerabilities on the epidemic; and describes in general terms the public health and clinical approaches to prevention and treatment of HIV/AIDS. Special risk factors and barriers to treatment of HIV/AIDS in LGBTQ people are also examined.


HIV HIV/AIDS Seroadaption Serosorting Pre-exposure prophylaxis HIV pathophysiology HIV prevention HIV stigma 


  1. A Timeline of HIV and AIDS. Accessed February 2, 2019.
  2. Aberg J, Gallant J, Ghanem K, Emmanuel P, Zingman B, Horberg M. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clin Infect Dis. 2013;58(1):e1–e34. Scholar
  3. AIDSinfo. National Institutes of Health. Accessed February 2, 2019.
  4. Altman L. New homosexual disorder worries health officials. New York: New York Times; 1982.Google Scholar
  5. American Academy of HIV Medicine. Accessed February 2, 2019.
  6. Amirkhanian Y. Social networks, sexual networks and HIV risk in men who have sex with men. Curr HIV/AIDS Rep. 2014;11(1):81–92. Scholar
  7. Angell M. A dual approach to the AIDS epidemic. N Engl J Med. 1991;324(21):1498–500.CrossRefGoogle Scholar
  8. Antiretroviral drugs used in the treatment of HIV infection. Published 2018. Accessed February 2, 2019.
  9. Baral S, Poteat T, Strömdahl S, Wirtz A, Guadamuz T, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13(3):214–22. Scholar
  10. Bavinton B, Pinto A, Phanuphak N, Grinsztejn B, Prestage GP, Zablotska-Manos IB, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–47. Scholar
  11. Bayer R, Fairchild A. Changing the paradigm for HIV testing — the end of exceptionalism. N Engl J Med. 2006;355(7):647–9. Scholar
  12. Bayer R. Public health policy and the AIDS epidemic. N Engl J Med. 1991;324(21):1500–4. Scholar
  13. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006–2017. Am J Public Health. 2018;109(1):e1–8.Google Scholar
  14. Becker G, Newsom E. Socioeconomic status and dissatisfaction with health care among chronically ill African Americans. Am J Public Health. 2003;93(5):742–8.CrossRefGoogle Scholar
  15. Becker MH, Joseph JG. AIDS and behavioral change to reduce risk: a review. Am J Public Health. 1988;78(4):394–410.CrossRefGoogle Scholar
  16. Bockting WO, Robinson BE, Rosser BR. Transgender HIV prevention: a qualitative needs assessment. AIDS Care. 1998;10(4):505–25.CrossRefGoogle Scholar
  17. Bowers JR, Branson CM, Fletcher JB, Reback CJ. Predictors of HIV sexual risk behavior among men who have sex with men, men who have sex with men and women, and transgender women. Int J Sex Health. 2012;24(4):290–302.CrossRefGoogle Scholar
  18. Brew B, Chan P. Update on HIV dementia and HIV-associated neurocognitive disorders. Curr Neurol Neurosci Rep. 2014;14(8):468. Scholar
  19. Brooks V. Minority stress and lesbian women. Lexington: Lexington Books; 1982.Google Scholar
  20. Casagrande S, Gary T, LaVeist T, Gaskin D, Cooper L. Perceived discrimination and adherence to medical care in a racially integrated community. J Gen Intern Med. 2007;22(3):389–95. Scholar
  21. Cassels S, Katz D. Seroadaptation among men who have sex with men: emerging research themes. Curr HIV/AIDS Rep. 2013;10(4):305–13. Scholar
  22. Castro H, Pillay D, Cane P, Asboe D, Cambiano V, Phillips A, Dunn DT. Persistence of HIV-1 transmitted drug resistance mutations. J Infect Dis. 2013;208(9):1459–63.CrossRefGoogle Scholar
  23. Centers for Disease Control and Prevention. HIV and African American gay and bisexual men. Atlanta: Centers for Disease Control and Prevention; 2018. Accessed February 2, 2019.Google Scholar
  24. Centers for Disease Control and Prevention. HIV and Gay and Bisexual Men. Atlanta: Centers for Disease Control and Prevention; 2018. Accessed February 2, 2019.Google Scholar
  25. Centers for Disease Control and Prevention. HIV and young men who have sex with men. Atlanta: Centers for Disease Control and Prevention; 2014. Accessed February 2, 2019Google Scholar
  26. Centers for Disease Control and Prevention. Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention: US Public Health Service; 2018. Accessed February 2, 2019.Google Scholar
  27. Centers for Disease Control. Changes in sexual behavior and condom use associated with a risk-reduction program–Denver, 1988–1991. MMWR Morb Mortal Wkly Rep. 1992;41(23):412–5.Google Scholar
  28. Centers for Disease Control. Patterns of sexual behavior change among homosexual/bisexual men–selected U.S. sites, 1987–1990. MMWR Morb Mortal Wkly Rep. 1991;40(46):792–4.Google Scholar
  29. Chan P, Brew B. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment. Curr HIV/AIDS Rep. 2014;11(3):317–24. Scholar
  30. Chan SK, Thornton LR, Chronister KJ, Meyer J, Wolverton M, Johnson CK, et al. Likely female-to-female sexual transmission of HIV–Texas, 2012. MMWR Morb Mortal Wkly Rep. 2014;63(10):209–12.PubMedPubMedCentralGoogle Scholar
  31. Chu C, Selwyn P. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. J Urban Health. 2011;88(3):556–66. Scholar
  32. Cohen J. HIV treatment as prevention. Science. 2011;334(6063):1628–1628. Scholar
  33. Cohen M, Shaw G, McMichael A, Haynes B. Acute HIV-1 infection. N Engl J Med. 2011;364(20):1943–54. Scholar
  34. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004;12(4):104–7.PubMedGoogle Scholar
  35. Cooper F, Barber T. Gay bowel syndrome. Curr Opin Infect Dis. 2014;27(1):84–9. Scholar
  36. De Santis J. HIV infection risk factors among male-to-female transgender persons: a review of the literature. J Assoc Nurses AIDS Care. 2009;20(5):362–72. Scholar
  37. Drescher S, von Wyl V, Yang W, Böni J, Yerly S, Shah C, et al. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV cohort study. Clin Infect Dis. 2013;58(2):285–94. Scholar
  38. First report of AIDS. MMWR Morb Mortal Wkly Rep. 2001;50(21):429.Google Scholar
  39. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987;317(4):185–91.CrossRefGoogle Scholar
  40. Gallant JE, Adimora AA, Carmichael JK, Horberg M, Kitahata M, Quinlivan EB, et al. Essential components of effective HIV care: a policy paper of the HIV medicine association of the Infectious Diseases Society of America and the Ryan White Medical Providers Coalition. Clin Infect Dis. 2011;53(11):1043–50. Scholar
  41. Gandhi R, Sax P, Grinspoon S. Metabolic and cardiovascular complications in HIV-infected patients: new challenges for a new age. J Infect Dis. 2012;205(suppl3):S353–4. Scholar
  42. Gardner E, McLees M, Steiner J, del Rio C, Burman W. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. Scholar
  43. GLMA: Health Professionals Advancing LGBTQ Equality. Accessed February 2, 2019.
  44. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337(11):734–9.CrossRefGoogle Scholar
  45. Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, et al. A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med. 1997;337(11):725–33. Scholar
  46. Health Resources and Services Administration. Workforce capacity in HIV. Rockville: Health Resources and Services Administration, HIV/AIDS Bureau; 2010.Google Scholar
  47. Herbst JH, Jacobs ED, Finlayson TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review. AIDS Behav. 2008;12(1):1–17.CrossRefGoogle Scholar
  48. HIV Among Transgender People. Published 2018. Accessed February 1, 2019.
  49. HIV Among Transgender People. Published 2018. Accessed February 1, 2019.
  50. HIV in the United States and Dependent Areas. Published 2019. Accessed February 2, 2019.
  51. HIV Medicine Association. Published 2019. Accessed February 2, 2019.
  52. Holloway IW, Rice E, Gibbs J, Winetrobe H, Dunlap S, Rhoades H. Acceptability of smartphone application-based HIV prevention among young men who have sex with men. AIDS Behav. 2014;18(2):285–96. Scholar
  53. Hughes E, Bassi S, Gilbody S, Bland M, Martin F. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(1):40–8. Scholar
  54. International Antiviral Society–USA. IAS-USA. Accessed February 2, 2019.
  55. Kelly J, DiFranceisco W, St Lawrence J, Amirkhanian Y, Anderson-Lamb M. Situational, partner, and contextual factors associated with level of risk at Most recent intercourse among black men who have sex with men. AIDS Behav. 2013;18(1):26–35. Scholar
  56. Lambda Legal. When health care Isn’t caring. Lambda Legal’s survey on discrimination against LGBT people and people living with HIV. New York City: Lambda Legal; 2010. Accessed February 2, 2019.
  57. Lasry A, Sansom S, Wolitski R, et al. HIV sexual transmission risk among serodiscordant couples. AIDS. 2014;28(10):1521–9. Scholar
  58. Lewnard J, Berrang-Ford L. Internet-based partner selection and risk for unprotected anal intercourse in sexual encounters among men who have sex with men: a meta-analysis of observational studies. Sex Transm Infect. 2014;90(4):290–6. Scholar
  59. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One. 2010;5(9):e12598. Scholar
  60. Maartens G, Celum C, Lewin S. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–71. Scholar
  61. Maiorana A, Koester K, Myers J, Lloyd KC, Shade SB, Dawson-Rose C, Morin SF. Helping patients talk about HIV: inclusion of messages on disclosure in prevention with positives interventions in clinical settings. AIDS Educ Prev. 2012;24(2):179–92. Scholar
  62. Masur H, Brooks J, Benson C, Holmes K, Pau A, Kaplan J. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the centers for disease control and prevention, national institutes of health, and HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58(9):1308–11. Scholar
  63. Mccusker J, Stoddard AM, Mcdonald M, Zapka JG, Mayer KH. Maintenance of behavioral change in a cohort of homosexually active men. AIDS. 1992;6(8):861–8.CrossRefGoogle Scholar
  64. Meade C, Fitzmaurice G, Sanchez A, Griffin M, McDonald L, Weiss R. The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. AIDS Behav. 2010;15(8):1829–33. Scholar
  65. Meade C, Sikkema K. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433–57. Scholar
  66. Meyer IH. Minority stress and mental health in gay men. J Health Soc Behav. 1995;36(1):38–56.CrossRefGoogle Scholar
  67. Muessig KE, Pike EC, Fowler B, LeGrand S, Parsons JT, Bull SS, et al. Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. AIDS Patient Care STDs. 2013;27(4):211–22. Scholar
  68. Muessig KE, Pike EC, Legrand S, Hightow-Weidman LB. Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: a review. J Med Internet Res. 2013;15(1):e1. Scholar
  69. Mugo N, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy. AIDS. 2011;25(15):1887–95. Scholar
  70. Mustanski B, Newcomb M, Du Bois S, Garcia S, Grov C. HIV in young men who have sex with men: a review of epidemiology, risk and protective factors, and interventions. J Sex Res. 2011;48(2–3):218–53. Scholar
  71. Mutua F, M’Imunya J, Wiysonge C. Genital ulcer disease treatment for reducing sexual acquisition of HIV. Cochrane Database Syst Rev. 2012;
  72. Nasrullah M, Wesolowski L, Meyer W, et al. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS. 2013;27(5):731–7. Scholar
  73. Nemoto T, Operario D, Soma T, Bao D, Vajrabukka A, Crisostomo V. HIV risk and prevention among Asian/Pacific islander men who have sex with men: listen to our stories. AIDS Educ Prev. 2003;15(1 Suppl A):7–20.CrossRefGoogle Scholar
  74. Nemoto T, Sausa L, Operario D, Keatley J. Need for HIV/AIDS education and intervention for MTF transgenders. J Homosex. 2006;51(1):183–201. Scholar
  75. Okulicz J, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS. 2011;6(3):163–8. Scholar
  76. Önen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci. 2011;4(1):33–41.CrossRefGoogle Scholar
  77. Patel P, Borkowf C, Brooks J, Lasry A, Lansky A, Mermin J. Estimating per-act HIV transmission risk. AIDS. 2014;28(10):1509–19. Scholar
  78. Pathai S, Bajillan H, Landay A, High K. Is HIV a model of accelerated or accentuated aging? J Gerontol Ser A Biol Med Sci. 2013;69(7):833–42. Scholar
  79. Pearshouse R. U.S.: All states to move to names-based HIV reporting in 2007. HIV AIDS Policy Law Rev. 2007;12(1):37–8.PubMedGoogle Scholar
  80. Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection–United States, 2014. MMWR Recomm Rep. 2014;63(RR-03):1–10.Google Scholar
  81. Robinson R, Moodie-Mills A. HIV/AIDS inequality: structural barriers to prevention, treatment, and care. In: Communities of color. Why we need a holistic approach to eliminate racial disparities in HIV/AIDS. Berkeley: Center for American Progress; 2012.Google Scholar
  82. Rodger AJ. Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: the PARTNER2 study extended results in gay men. Presented at the 22nd international AIDS conference; July 23–27, 2018; Amsterdam, the Netherlands.Google Scholar
  83. Ruan Y, Qian H, Li D, Shi W, Li Q, Liang H, et al. Willingness to be circumcised for preventing HIV among Chinese men who have sex with men. AIDS Patient Care STDs. 2009;23(5):315–21. Scholar
  84. Scarce M. Harbinger of plague: a bad case of gay bowel syndrome. J Homosex. 1997;34(2):1–35.CrossRefGoogle Scholar
  85. Simoni JM, Pantalone DW. Secrets and safety in the age of AIDS: does HIV disclosure lead to safer sex? Top HIV Med. 2004;12(4):109–18.PubMedGoogle Scholar
  86. Smith D, Mathews W. Physicians’ attitudes toward homosexuality and HIV. J Homosex. 2007;52(3–4):1–9. Scholar
  87. Snelgrove J, Jasudavisius A, Rowe B, Head E, Bauer G. “Completely out-at-sea” with “two-gender medicine”: a qualitative analysis of physician-side barriers to providing healthcare for transgender patients. BMC Health Serv Res. 2012;12(1)
  88. Sood N, Juday T, Vanderpuye-Orgle J, Rosenblatt L, Romley JA, Peneva D, Goldman DP. HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff. 2014;33(3):394–400. Scholar
  89. Tobian A, Kacker S, Quinn T. Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med. 2014;65(1):293–306. Scholar
  90. Tyerman Z, Aboulafia DM. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy. AIDS Rev. 2012;14(1):3–16.PubMedGoogle Scholar
  91. Vamvakas E. Relative risk of reducing the lifetime blood donation deferral for men who have had sex with men versus currently tolerated transfusion risks. Transfus Med Rev. 2011;25(1):47–60. Scholar
  92. van den Boom W, Konings R, Davidovich U, Sandfort T, Prins M, Stolte I. Is serosorting effective in reducing the risk of HIV infection among men who have sex with men with casual sex partners? JAIDS J Acquir Immune Defic Syndr. 2014;65(3):375–9. Scholar
  93. Volberding P, Greene W, Lange J, Gallant J. Sande’s HIV/AIDS medicine. 2nd ed. Philadelphia: Elsevier Saunders; 2012.Google Scholar
  94. Wagner Z, Wu Y, Sood N. The affordable care act may increase the number of people getting tested for HIV by nearly 500,000 by 2017. Health Aff. 2014;33(3):378–85. Scholar
  95. Wang C, Silverberg M, Abrams D. Non-AIDS-defining malignancies in the HIV-infected population. Curr Infect Dis Rep. 2014;16(6):406. Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Brian A. Nuyen
    • 1
  • Jennifer L. Glick
    • 2
  • Vanessa Ferrel
    • 3
  • W. Christopher Mathews
    • 4
  1. 1.Stanford University School of MedicineStanfordUSA
  2. 2.Johns Hopkins Bloomberg School of Public HealthBaltimoreUSA
  3. 3.Montefiore Medical CenterThe BronxUSA
  4. 4.Department of MedicineUniversity of California San DiegoLa JollaUSA

Personalised recommendations